[Federal Register Volume 60, Number 235 (Thursday, December 7, 1995)]
[Notices]
[Pages 62883-62884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29772]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 31, 1995, and published in the Federal Register
on June 8, 1995, (60 FR 30318), Radian Corporation, P.O. Box 201088,
8501 Mopac Blvd., Austin, Texas 78720, made application to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed
below:
Schedule
Drug:
Cathinone (1235).......................... I
Methcathinone (1237) I
N-Ethylamphetamine (1475)................. I
N,N-Dimethylamphetamine (1480)............ I
Aminorex (1585)........................... I
4-Methylaminorex (cis isomer) (1590)...... I
Methaqualone (2565)....................... I
Lysergic acid diethylamide (7315)......... I
Tetrahydrocannabinols (7370).............. I
Mescaline (7381).......................... I
3,4-Methylenedioxyamphetamine (7400)...... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405).. I
4-Methoxyamphetamine (7411)............... I
Psilocybin (7437)......................... I
Psilocyn (7438)........................... I
Dihydromorphine (9145).................... I
[[Page 62884]]
Normorphine (9313)........................ I
Acetylmethadol (9601)..................... I
Alphacetylmethadol except Levo- I
Alphacetylmethadol (9603).
Normethadone (9635)....................... I
3-Methylfentanyl (9813)................... I
Amphetamine (1100)........................ II
Methamphetamine (1105).................... II
Methylphenidate (1724).................... II
Amobarbital (2125)........................ II
Pentobarbital (2270)...................... II
Secobarbital (2315)....................... II
Phencyclidine (7471)...................... II
1-Piperidinocyclohexane-.................. II
carbonitrile (8603).......................
Dihydrocodeine (9120)..................... II
Oxycodone (9143).......................... II
Hydromorphone (9150)...................... II
Diphenoxylate (9170)...................... II
Benzoylecgonine (9180).................... II
Ethylmorphine (9190)...................... II
Hydrocodone (9193)........................ II
Isomethadone (9226)....................... II
Meperidine (9230)......................... II
Methadone (9250).......................... II
Methadone-intermediate (9254)............. II
Morphine (9300)........................... II
Levo-alphacetylmethadol (9648)............ II
Oxymorphone (9652)........................ II
Alfentanil (9737)......................... II
Sufentanil (9740)......................... II
Fentanyl (9801)........................... II
A registered manufacturer filed a request for a hearing with
respect to amphetamine and methamphetamine. The requesting party
subsequently submitted a letter dated August 29, 1995, withdrawing
their request for a hearing. On September 1, 1995, an order terminating
the proceedings was issued by Administrative Law Judge Mary Ellen
Bittner. Another registered manufacturer filed a comment requesting
that the firm's application to manufacture meperidine be denied because
there is no need for Radian to register as a third domestic
manufacturer of meperidine and that Radian must show it can maintain
adequate safeguards against the theft and diversion of meperidine. In
regards to this comment, the firm, which has been approved as a
manufacturer of meperidine for previous applications, has been subject
to periodic in-depth investigations by DEA to evaluate the firm's
fitness as a DEA registrant. Additionally, in response to this recent
application, the firm was inspected by DEA and found to have adequate
safeguards to prevent the theft or diversion of meperidine. Therefore,
pursuant to Section 303 of the Comprehensive Drug Abuse Prevention and
Control Act of 1970 and Title 21, Code of Federal Regulations, Section
1301.54(e), the Deputy Assistant Administrator, Office of Diversion
Control, hereby orders that the application submitted by the above firm
for registration as a bulk manufacturer of the basic classes of
controlled substances listed above is granted.
Dated: November 29, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 95-29772 Filed 12-6-95; 8:45 am]
BILLING CODE 4410-09-M